Patent Yard Sign in
Canadian application, no grantCanada

Spirocyclic benzopyran imidazolines

CA 2113818 A1 · Owner: The Upjohn Company · Inventors: Gadwood, Robert C.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Spiro-4H-1-benzopyran-4,4'-5'H-imidazol-5'-ones of Formula (1) wherein R1 is H, R2, F, Cl, Br, CF3, CF3O CN, NO2, R2SO2, R2NHSO2, R2O, R2CO, R2OCO or R2NHCO. R2, is a C1-C10 branched or linear alkyl a C3-8 cycloalkyl, phenyl, or benzyl. X can be S O, or NH. Both enantiomers are, included in this invention as well as salts and tautomeric forms of these compounds. The subject compounds are useful in the treatment of hypertension, alopecia, and erectile dysfunction.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 3, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 3, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 3, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 3, 1992
GrantedNo grant recorded
Term endedAugust 3, 2012
Patent numberCA 2113818 A1
Classification (IPC)C07D491/10 +2 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedAug 3, 1992Term endedAug 3, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.